Patent · US Active

Targeted self-assembly of functionalized carbon nanotubes on tumors

US10900037B2 · kind B2 · utility

0Cited by

1References

7Claims

0Family size

Inventors

David A. Scheinberg · New York, US
Michael R. McDevitt · New York, US
Carlos H. Villa · Philadelphia, US
J. Justin Mulvey · New York, US

Key dates

Filing date	May 22, 2018
Grant date	Jan 26, 2021
Priority date	—
Expiry date	May 22, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/906
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein is the two component self-assembly single wall nanotube system and the single wall nanotube construct that is the second component. The two component self-assembly single wall nanotube system has a morpholino oligonucleotide with a targeting moiety followed by a single wall nanotube construct with second morpholino oligonucleotides complementary to the first morpholino oligonucleotides and one or both of a therapeutic or diagnostic payload molecule linked to the single wall nanotube construct.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.